ESR1 and breast cancer: For example, IGF-1R expression has been shown to be positively correlated with improved breast cancer specific survival among patients with ER positive tumors, while its expression was associated with an inferior prognosis in patients with HER2-overexpressing or triple negative tumors.[6–9]